Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
AbbVie Inc. ABBV
$146.17
-$0.42 (-0.29%)
На 18:00, 12 мая 2023
+7.55%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
257806883264.00000000
-
week52high
168.11
-
week52low
134.09
-
Revenue
58054000000
-
P/E TTM
34
-
Beta
0.55328700
-
EPS
4.25000000
-
Last Dividend
5.92000000
-
Next Earnings Date
27 июл 2023 г. в 12:30
Описание компании
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Argus Research | Buy | Buy | 24 авг 2022 г. |
| UBS | Neutral | Neutral | 01 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 01 авг 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 01 авг 2022 г. |
| Atlantic Equities | Neutral | Neutral | 01 авг 2022 г. |
| SVB Leerink | Underperform | Underperform | 30 сент 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 31 окт 2022 г. |
| BMO Capital | Outperform | Outperform | 31 окт 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 31 окт 2022 г. |
| Atlantic Equities | Neutral | Neutral | 31 окт 2022 г. |
| Societe Generale | Hold | Buy | 08 ноя 2022 г. |
| Credit Suisse | Outperform | 18 ноя 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 06 дек 2022 г. |
| Piper Sandler | Overweight | Overweight | 17 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| RAPP EDWARD J | A | 23256 | 239 | 31 дек 2022 г. |
| Alpern Robert J | A | 8723 | 46 | 31 дек 2022 г. |
| RICHMOND TIMOTHY J. | D | 0 | 42370 | 12 дек 2022 г. |
| RICHMOND TIMOTHY J. | D | 13837 | 3075 | 12 дек 2022 г. |
| RICHMOND TIMOTHY J. | D | 16912 | 39295 | 12 дек 2022 г. |
| RICHMOND TIMOTHY J. | A | 56207 | 42370 | 12 дек 2022 г. |
| RAPP EDWARD J | A | 22806 | 288 | 30 сент 2022 г. |
| Alpern Robert J | A | 8598 | 55 | 30 сент 2022 г. |
| RAPP EDWARD J | A | 22296 | 237 | 30 июн 2022 г. |
| Alpern Robert J | A | 8458 | 47 | 30 июн 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 49672800 | -426519 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 36212200 | -131131 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 18587500 | -88146 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 15141100 | -70504 | 31 авг 2020 г. |
| iShares Core S&P 500 ETF | 13334100 | -72420 | 31 авг 2020 г. |
| Vanguard Value Index Fund | 11810300 | 704670 | 31 авг 2020 г. |
| Health Care Select Sector SPDR Fund | 10749700 | 68334 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 15698000 | -16988 | 31 июл 2020 г. |
| American Funds Capital Income Builder | 22584000 | 4763500 | 30 июн 2020 г. |
| American Funds American Mutual Fund | 10747200 | 0 | 30 июн 2020 г. |
Новостная лента
AbbVie Or Johnson & Johnson? Let's Ask Peter Lynch
Seeking Alpha
09 мая 2023 г. в 06:40
Many investors do not consider Peter Lynch to be a dividend investor – an unfortunate misunderstanding in my view. He has so many valuable insights into dividend stocks. It is just these insights are overshadowed by his success with 10-baggers.
7 Dividend Stocks That Will Pay You Through Any Market Turmoil
InvestorPlace
08 мая 2023 г. в 20:17
While there's nothing quite as exciting as betting everything on a hot growth enterprise, prudent investors may want to consider the best dividend stocks for market crash. In late April, CNBC reported that investors face the threat of persistently higher inflation while simultaneously digesting a bleak economic outlook.
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
The Motley Fool
06 мая 2023 г. в 09:44
AbbVie just reported poor earnings, and there may be regulatory headwinds coming. Despite that, things appear to be going according to management's plan.
Looking for Steady, Passive Income? Buy AbbVie Stock
The Motley Fool
06 мая 2023 г. в 09:00
As expected, AbbVie's revenue and earnings both dropped in Q1. However, the drug company offers a sizable dividend that is well-covered.
7 Dividend-Paying Large-Cap Stocks to Buy in May
InvestorPlace
04 мая 2023 г. в 16:41
Large-cap stocks are those that have a market capitalization above $10 billion and are synonymously known as big cap stocks. Market cap is calculated by multiplying the share price by the number of shares outstanding.